- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Fitbit is reportedly buying rival Pebble for a fraction of what Pebble was offered in 2015. The deal shows how both consumer and investor enthusiasm for wearables has cooled markedly.
Tech giants, Big Pharma and insurers are all angling to profit from the $3 trillion-plus U.S. healthcare market.